Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura McDonald

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Disease Models & Mechanisms|March 15, 2014
RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary glandLaura McDonald, Nicola Ferrari, Anne Terry, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive DisorderLaura McDonald, Roseann O' Doherty, Eileen Ryan, et al.
Journal of Anatomy|November 30, 2007
Micro-magnetic resonance imaging of avian embryosXiaojing Li, Jia Liu, Megan Davey, et al.
Therapeutic Advances in Medical Oncology|March 31, 2022
A population-based study in synchronous <i>versus</i> metachronous metastatic esophagogastric adenocarcinomaMarieke Pape, Pauline A J Vissers, David Bertwistle, et al.
JAMA|July 4, 2013
Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trialMark Ledwidge, Joseph Gallagher, Carmel Conlon, et al.
The British Journal of Surgery|August 23, 2022
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancerMarieke Pape, Pauline A J Vissers, David Bertwistle, et al.
Cancer Research|March 12, 2020
RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical OutcomeNicholas Rooney, Susan M Mason, Laura McDonald, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
The Journal of Cell Biology|October 24, 2012
N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopodsXinzi Yu, Tobias Zech, Laura McDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2024
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial DataGeorgina V Long, Evan J Lipson, F Stephen Hodi, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Disease Models & Mechanisms|March 15, 2014
RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary glandLaura McDonald, Nicola Ferrari, Anne Terry, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive DisorderLaura McDonald, Roseann O' Doherty, Eileen Ryan, et al.
Journal of Anatomy|November 30, 2007
Micro-magnetic resonance imaging of avian embryosXiaojing Li, Jia Liu, Megan Davey, et al.
Therapeutic Advances in Medical Oncology|March 31, 2022
A population-based study in synchronous <i>versus</i> metachronous metastatic esophagogastric adenocarcinomaMarieke Pape, Pauline A J Vissers, David Bertwistle, et al.
JAMA|July 4, 2013
Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trialMark Ledwidge, Joseph Gallagher, Carmel Conlon, et al.
The British Journal of Surgery|August 23, 2022
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancerMarieke Pape, Pauline A J Vissers, David Bertwistle, et al.
Cancer Research|March 12, 2020
RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical OutcomeNicholas Rooney, Susan M Mason, Laura McDonald, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
The Journal of Cell Biology|October 24, 2012
N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopodsXinzi Yu, Tobias Zech, Laura McDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2024
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial DataGeorgina V Long, Evan J Lipson, F Stephen Hodi, et al.
Pageof 7